AU509631B2 - Somatostatin analogues - Google Patents

Somatostatin analogues

Info

Publication number
AU509631B2
AU509631B2 AU25775/77A AU2577577A AU509631B2 AU 509631 B2 AU509631 B2 AU 509631B2 AU 25775/77 A AU25775/77 A AU 25775/77A AU 2577577 A AU2577577 A AU 2577577A AU 509631 B2 AU509631 B2 AU 509631B2
Authority
AU
Australia
Prior art keywords
somatostatin analogues
somatostatin
analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU25775/77A
Other versions
AU2577577A (en
Inventor
W. W. Jr Rivier J. E. and Brown MR Vale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Salk Institute for Biological Studies
Original Assignee
Salk Institute for Biological Studies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/785,533 external-priority patent/US4133782A/en
Application filed by Salk Institute for Biological Studies filed Critical Salk Institute for Biological Studies
Publication of AU2577577A publication Critical patent/AU2577577A/en
Application granted granted Critical
Publication of AU509631B2 publication Critical patent/AU509631B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU25775/77A 1976-06-07 1977-06-02 Somatostatin analogues Expired AU509631B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US69328276A 1976-06-07 1976-06-07
USUS693282 1976-06-07
US05/785,533 US4133782A (en) 1976-06-07 1977-04-07 Somatostatin analogs with dissociated biological activities
USUS785533 1977-04-07

Publications (2)

Publication Number Publication Date
AU2577577A AU2577577A (en) 1978-12-07
AU509631B2 true AU509631B2 (en) 1980-05-22

Family

ID=27105142

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25775/77A Expired AU509631B2 (en) 1976-06-07 1977-06-02 Somatostatin analogues

Country Status (11)

Country Link
JP (1) JPS52156885A (en)
AU (1) AU509631B2 (en)
CA (1) CA1102313A (en)
CH (1) CH640827A5 (en)
DE (1) DE2725735A1 (en)
DK (1) DK250977A (en)
FR (1) FR2375190A1 (en)
GB (1) GB1567341A (en)
IL (1) IL52231A (en)
NL (1) NL7706002A (en)
SE (1) SE441452B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904594A (en) * 1973-07-02 1975-09-09 Salk Inst For Biological Studi Somatostatin and acylated des-(ala' 1', gly' 2') derivatives thereof
US3842067A (en) * 1973-07-27 1974-10-15 American Home Prod Synthesis of(des-asn5)-srif and intermediates

Also Published As

Publication number Publication date
FR2375190A1 (en) 1978-07-21
FR2375190B1 (en) 1981-10-30
AU2577577A (en) 1978-12-07
IL52231A (en) 1980-05-30
JPS52156885A (en) 1977-12-27
CH640827A5 (en) 1984-01-31
NL7706002A (en) 1977-12-09
SE7706567L (en) 1977-12-08
IL52231A0 (en) 1977-08-31
SE441452B (en) 1985-10-07
GB1567341A (en) 1980-05-14
DE2725735A1 (en) 1977-12-15
DK250977A (en) 1977-12-08
CA1102313A (en) 1981-06-02
JPS6315280B2 (en) 1988-04-04

Similar Documents

Publication Publication Date Title
AU502587B2 (en) Prostaglandin analogues
AU525781B2 (en) Vitamin d analogues
AU508162B2 (en) Calcitonin analogues
AU510088B2 (en) Prostaglandin-acetylene analogues
GB1551929A (en) Somatostatin analogues
AU523732B2 (en) Enkephalin analogues
GB2016007B (en) W-halo-pgi2 analogues
AU500087B2 (en) Lh-rh analogues
AU502349B2 (en) 2-decarboxy-2-amino-prostaglandin analogues
AU517897B2 (en) Clavulanic acid analogues
JPS5461171A (en) Novel somatostatin analogues
AU4324879A (en) Untriacontapeptide (b-endorphin) analogues
AU510216B2 (en) 13-thiaprestaglandin analogues
AU514996B2 (en) Thymosin
AU509274B2 (en) Prostaglandin analogues
IL52367A (en) Somatostatin analogs
AU509631B2 (en) Somatostatin analogues
AU1545276A (en) Shower-bathtub
AU512644B2 (en) Prostaglandin analogues
AU526215B2 (en) 10-12-diaza prostaglanoin analogues
AU512595B2 (en) Prostaglandin analogues
AU518731B2 (en) Somatostatin analogs
GB2010280B (en) Somatostatin analogues
GB2015535A (en) Beta-endorphin analogues
MY8400115A (en) Somatostatin peptide analogues